These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38925251)

  • 1. Predictors of length of hospital stay and in-hospital adverse events in patients with acute decompensated heart failure: in-hospital 24-hour blood pressure monitoring data.
    Candemir M; Kızıltunç E; Nurkoç SG; Cihan B; Şahinarslan A
    Hellenic J Cardiol; 2024 Jun; ():. PubMed ID: 38925251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of ambulatory blood pressure monitoring data in patients with ankylosing spondylitis without clinically evident cardiovascular disease.
    Candemir M; Kiziltunç E; Candemir B; Nurkoç S; Cihan B; Şahinarslan A
    J Hum Hypertens; 2022 Jun; 36(6):531-536. PubMed ID: 33953331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory Arterial Stiffness Index (AASI) is Unable to Estimate Arterial Stiffness of Hypertensive Subjects: Role of Nocturnal Dipping of Blood Pressure.
    Di Raimondo D; Casuccio A; Di Liberti R; Musiari G; Zappulla V; D'Angelo A; Pinto A
    Curr Hypertens Rev; 2017; 13(2):121-131. PubMed ID: 28637401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New indices of arterial stiffness correlate with disease severity and mid-term prognosis in acute decompensated heart failure.
    Zhou J; Wang Y; Feng Y; Chen X; Zhang Q
    Intern Emerg Med; 2021 Apr; 16(3):661-668. PubMed ID: 32888111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.
    López-Vilella R; Marqués-Sulé E; Sánchez-Lázaro I; Laymito Quispe R; Martínez Dolz L; Almenar Bonet L
    Acta Cardiol; 2021 Dec; 76(10):1100-1107. PubMed ID: 33480331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between ambulatory arterial stiffness index and blood pressure variability in hypertensive patients.
    Lee HT; Lim YH; Kim BK; Lee KW; Lee JU; Kim KS; Kim SG; Kim JH; Lim HK; Shin J; Kim YM
    Korean Circ J; 2011 May; 41(5):235-40. PubMed ID: 21731563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In newly diagnosed hypertensive children, increased arterial stiffness and reduced heart rate variability were associated with a non-dipping blood pressure pattern.
    Cilsal E
    Rev Port Cardiol (Engl Ed); 2020 Jun; 39(6):331-338. PubMed ID: 32561230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure].
    Wei BQ; Yang YJ; Zhang J; Dou KF; Zhang YH; Huang XH; Kang LM; Zhang CL; Gu Q; Gao X; Yang YM; Dai Y; Yu LT; Zhang HM; Lü R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):481-5. PubMed ID: 19927625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
    Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
    ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point of care with serial NT-proBNP measurement in patients with acute decompensated heart failure as a therapy-monitoring during hospitalization (POC-HF): Study protocol of a prospective, unblinded, randomized, controlled pilot trial.
    Züsli S; Bierreth F; Boesing M; Haas P; Abig K; Maier S; Corridori G; Leuppi JD; Dieterle T
    Contemp Clin Trials Commun; 2021 Sep; 23():100825. PubMed ID: 34485753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal blood pressure rather than night-to-day blood pressure ratio is related to arterial stiffening in untreated young and middle-aged adults with non-dipper hypertension.
    Liu J; Su X; Nie Y; Zeng Z; Chen H;
    J Clin Hypertens (Greenwich); 2022 Aug; 24(8):1044-1050. PubMed ID: 35894760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of fluctuation and inverted circadian rhythm of blood pressure increase the risk of cognitive dysfunction in cerebral small vessel disease patients.
    Xu Y; Gong C; Liao J; Ge Z; Tan Y; Jiang Y; Liu M; Zhong W; Zhang X; Dong N; Shen X
    BMC Neurol; 2023 Feb; 23(1):73. PubMed ID: 36793019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of decompensated heart failure: role of NT-proBNP.
    Ferreira S; Almeida R; Guerrero H; Lourenço-Ferreira S; Fonseca L; Rocha R; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2007 May; 26(5):535-45. PubMed ID: 17691279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Blood Pressure Variability Ratio With Glomerular Filtration Rate Independent of Blood Pressure and Pulse Wave Velocity.
    Woodiwiss AJ; Norton GR; Ben-Dov IZ; Gavish B; Bursztyn M
    Am J Hypertens; 2017 Nov; 30(12):1177-1188. PubMed ID: 28992192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
    Bettencourt P; Azevedo A; Pimenta J; Friões F; Ferreira S; Ferreira A
    Circulation; 2004 Oct; 110(15):2168-74. PubMed ID: 15451800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
    ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of amino-terminal pro-brain natriuretic peptide testing on hospital length of stay and morbidity in patients with acute decompensated heart failure.
    Green SM; Redmond P; Januzzi JL; Aleryani S; Lee-Lewandrowski E; Sluss P; Lewandrowski KB
    Arch Pathol Lab Med; 2007 Mar; 131(3):473-6. PubMed ID: 17516751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.